Detail akcie Biostem Technologs online

Business Summary: Biostem Technologies, Inc. is a development-stage company. The Company is a biotechnology company focused on the development of anti-aging nutraceutical and cosmeceutical products, stem cell therapies, pharmaceuticals and educational provider of cell treatment protocols. The Company's divisions include Biostem Cell Therapy, Biostem Pharmaceuticals and Biostem Wellness. Biostem Cell Therapy provides stem cell therapies, stem cell banking, stem cell therapy, and stem cell research and development. Biostem Pharmaceuticals provides research and product development, active pharmaceutical ingredient (API) re-packaging and lab services. Biostem Wellness provides anti-aging and rejuvenation products and services, wellness and management programs, among others. The Company's subsidiaries include Biostem Wellness, Inc., Biostem Pharmaceuticals, Inc., Biostem Cell Therapy, Inc., Biostem International Inc. and Biostem Helps, Inc.
Financial Summary: BRIEF: For the six months ended 30 June 2018, Biostem Technologies Inc revenues decreased 50% to $99K. Net loss applicable to common stockholders decreased 22% to $2.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects General and administrative Expenses decrease of 26% to $2.2M (expense), Other income (expense) - net increase from $0K to $1K (income).